{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-012153","form_type":"8-K","ticker":"ALLR","cik":"0001860657","company_name":"Allarity Therapeutics, Inc.","filed_at":"2025-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.221289+00:00","generated_at":"2026-05-23T13:47:30.695952+00:00","sec_items":["5.02","5.08"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Allarity rebalances board classes, sets June 13 annual meeting","bullets":["Thomas H. Jensen resigned from Class I and immediately re-elected as Class III director, term expires 2028.","Board now consists of one Class I, two Class II, and one Class III director.","Annual meeting set for June 13, 2025; record date April 16, 2025.","Deadline for stockholder proposals and director nominations is April 28, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-012153","json":"https://secwatch.observer/filing/0001437749-25-012153.json","markdown":"https://secwatch.observer/filing/0001437749-25-012153.md","text":"https://secwatch.observer/filing/0001437749-25-012153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860657/000143774925012153/0001437749-25-012153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860657/000143774925012153/allr20250415_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T13:47:30.695952+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}